| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-IGF1R/CD221 mAbs [Robatumumab Biosimilar] (MABL-5179) | MABL-5179 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Rocatinlimab Biosimilar] (MABL-5180) | MABL-5180 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Roconkibart Biosimilar] (MABL-5181) | MABL-5181 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-RhD/CD240D/RhPI mAbs [Roledumab Biosimilar] (MABL-5182) | MABL-5182 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PRLR mAbs [Rolinsatamab Biosimilar] (MABL-5183) | MABL-5183 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LILRB4/CD85K mAbs [Rolistobart Biosimilar] (MABL-5184) | MABL-5184 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PVRIG/NECTIN2 receptor/CD112R mAbs [Remzistotug Biosimilar] (MABL-5156) | MABL-5156 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Renvistobart Biosimilar] (MABL-5157) | MABL-5157 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1;PDL1/CD274 mAbs [Reozalimab Biosimilar] (MABL-5158) | MABL-5158 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-IL5 mAbs [Reslizumab Biosimilar] (MABL-5159) | MABL-5159 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SOST mAbs [Resugosbart Biosimilar] (MABL-5160) | MABL-5160 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-RSV gpF mAbs [Retavibart Biosimilar] (MABL-5161) | MABL-5161 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Retifanlimab Biosimilar] (MABL-5162) | MABL-5162 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Retlirafusp Biosimilar] (MABL-5163) | MABL-5163 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Revdofilimab Biosimilar] (MABL-5164) | MABL-5164 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3;SIGLEC2/CD22 mAbs [Rezetamig Biosimilar] (MABL-5165) | MABL-5165 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-KLRB1 mAbs [Rezorstobart Biosimilar] (MABL-5166) | MABL-5166 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C1S mAbs [Riliprubart Biosimilar] (MABL-5167) | MABL-5167 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Rilogrotug Biosimilar] (MABL-5168) | MABL-5168 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HGF/SF mAbs [Rilotumumab Biosimilar] (MABL-5169) | MABL-5169 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
